Figure 2.
Virologic response to interferon (IFN) plus ribavirin at the end of treatment and 24 weeks thereafter in patients who were relapsers or nonresponders to a previous course of IFN monotherapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.